Total Voting Rights

RNS Number : 6550D
Futura Medical PLC
30 April 2013
 



For immediate release

30 April 2013

 

 

Futura Medical plc

("Futura" or "the company")

 

Total Voting Rights

 

Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology, announces that, for the purposes of the Disclosure and Transparency Rules, the Company's total issued share capital at the date of this announcement is 77,492,946 ordinary shares of 0.2p each, with one voting right per share. There are no shares held in treasury.

The total number of voting rights in the Company is therefore 77,492,946.

The above figure of 77,492,946 shares may be used by shareholders as a denominator for the calculations by which they will determine if they are required to notify their interest in, or change to their interest in, the Company, under the Disclosure and Transparency Rules.

 

For any further information please contact:

Futura Medical plc


James Barder, Chief Executive

Tel: +44 (0)1483 685 670

mail to: james.barder@futuramedical.com

www.futuramedical.com

 


Nomura Code Securities Limited


Phil Walker / Giles Balleny

Tel:+44 (0)20 7776 1200



For media enquiries please contact:




Buchanan

www.buchanan.uk.com

Mark Court / Fiona Henson / Sophie Cowles

Tel: +44 (0)20 7466 5000

 

Notes to Editors

 

Futura Medical plc

 

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

 

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

www.futuramedical.com

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TVRMMGFDKGDGFZM
UK 100

Latest directors dealings